|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.29 USD | -0.81% |
|
-2.92% | +3.45% |
| 01-15 | Embecta Corp. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 02:15 PM | |
| 01-14 | Embecta Seeks M&A | CI |
| Capitalization | 728M 620M 575M 540M 1.01B 66.23B 1.08B 6.63B 2.62B 31.49B 2.73B 2.67B 115B | P/E ratio 2026 * |
4.9x | P/E ratio 2027 * | 4.71x |
|---|---|---|---|---|---|
| Enterprise value | 728M 620M 575M 540M 1.01B 66.23B 1.08B 6.63B 2.62B 31.49B 2.73B 2.67B 115B | EV / Sales 2026 * |
0.67x | EV / Sales 2027 * | 0.67x |
| Free-Float |
98.8% | Yield 2026 * |
4.87% | Yield 2027 * | 4.87% |
More valuation ratios
* Estimated data
More news
Last Transcript: Embecta Corp.
More recommendations
More press releases
| 1 day | -0.81% | ||
| 1 week | -2.92% | ||
| Current month | +3.45% | ||
| 1 month | +4.60% | ||
| 3 months | -12.84% | ||
| 6 months | +25.66% | ||
| Current year | +3.45% |
| 1 week | 12.01 | 12.86 | |
| 1 month | 11.38 | 13.03 | |
| Current year | 11.38 | 13.03 | |
| 1 year | 9.2 | 19.67 | |
| 3 years | 9.2 | 33.88 | |
| 5 years | 0 | 49 | |
| 10 years | 0 | 49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Devdatt Kurdikar
CEO | Chief Executive Officer | 58 | 21/03/2022 |
Jacob Elguicze
DFI | Director of Finance/CFO | 53 | 21/03/2022 |
Colleen Riley
CTO | Chief Tech/Sci/R&D Officer | 62 | 30/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Devdatt Kurdikar
BRD | Director/Board Member | 58 | 31/03/2022 |
Robert Hombach
BRD | Director/Board Member | 60 | 19/03/2022 |
David Melcher
CHM | Chairman | 72 | 31/03/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.81% | -2.92% | -34.21% | -48.19% | 728M | ||
| -0.51% | -2.54% | +6.75% | +7.37% | 211B | ||
| +1.90% | +2.26% | +11.94% | +21.86% | 126B | ||
| -1.18% | +1.38% | +44.88% | +116.18% | 68.03B | ||
| -1.80% | +0.93% | -14.32% | -19.87% | 57.95B | ||
| -0.58% | -4.08% | +17.27% | +82.13% | 53.7B | ||
| +0.07% | +3.03% | - | - | 36.74B | ||
| +1.71% | +0.68% | -16.18% | -34.42% | 27.59B | ||
| -3.97% | -0.72% | +23.08% | +25.78% | 25.32B | ||
| -2.33% | -3.86% | -1.13% | -36.16% | 23.56B | ||
| Average | -0.76% | +1.03% | +4.23% | +12.74% | 63.07B | |
| Weighted average by Cap. | -0.11% | +0.77% | +10.39% | +24.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 921M 853M 802M 1.49B 98.3B 1.6B 9.85B 3.89B 46.74B 4.05B 3.97B 171B | 1.08B 924M 856M 805M 1.5B 98.63B 1.61B 9.88B 3.9B 46.9B 4.06B 3.98B 171B |
| Net income | 150M 128M 119M 111M 207M 13.66B 223M 1.37B 540M 6.49B 563M 551M 23.7B | 159M 135M 125M 118M 220M 14.46B 236M 1.45B 572M 6.88B 596M 584M 25.09B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,850
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/01/26 | 12.29 $ | -0.81% | 398,965 |
| 16/01/26 | 12.39 $ | -1.67% | 435,897 |
| 15/01/26 | 12.60 $ | -1.18% | 382,324 |
| 14/01/26 | 12.75 $ | +0.71% | 321,042 |
| 13/01/26 | 12.66 $ | -1.48% | 456,280 |
Delayed Quote Nasdaq, January 20, 2026 at 09:00 pm
More quotesSell
Buy

Mean consensus
HOLD
Number of Analysts
4
Last Close Price
12.29USD
Average target price
16.67USD
Spread / Average Target
+35.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EMBC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















